Biopol Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Operating Revenue	811.43	491.28	174.33
Other Revenue	2.28	-	-
Revenue	813.72	491.28	174.33
Revenue Growth (YoY)	65.63%	181.82%	-
Cost of Revenue	631	402.86	146.42
Gross Profit	182.71	88.42	27.91
Selling, General & Admin	17.89	14.48	3.5
Other Operating Expenses	28.05	8.54	5.62
Operating Expenses	46.92	23.73	9.52
Operating Income	135.79	64.69	18.38
Interest Expense	-15.21	-5.05	-0.81
Currency Exchange Gain (Loss)	-	0.16	-0.02
Other Non Operating Income (Expenses)	0	-1.77	-0.43
Pretax Income	120.58	58.04	17.12
Income Tax Expense	30.84	14.74	4.31
Net Income	89.74	43.3	12.81
Net Income to Common	89.74	43.3	12.81
Net Income Growth	107.25%	238.08%	-
Shares Outstanding (Basic)	8	8	-
Shares Outstanding (Diluted)	8	8	-
Shares Change (YoY)	4.74%	-	-
EPS (Basic)	10.83	5.47	-
EPS (Diluted)	10.83	5.47	-
EPS Growth	97.99%	-	-
Free Cash Flow	-269.66	-23.61	-89.43
Free Cash Flow Per Share	-32.54	-2.98	-
Gross Margin	22.45%	18.00%	16.01%
Operating Margin	16.69%	13.17%	10.54%
Profit Margin	11.03%	8.81%	7.35%
Free Cash Flow Margin	-33.14%	-4.81%	-51.30%
EBITDA	136.77	65.39	18.78
EBITDA Margin	16.81%	13.31%	10.77%
D&A For EBITDA	0.98	0.7	0.4
EBIT	135.79	64.69	18.38
EBIT Margin	16.69%	13.17%	10.54%
Effective Tax Rate	25.58%	25.40%	25.19%
Revenue as Reported	813.72	491.51	174.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.